Docetaxel for hormone-sensitive metastatic prostate cancer

被引：3
|
作者：
Baker, Holly
机构：
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(15)00227-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：E432 / E432
页数：1
相关论文
共 50 条
  • [1] Docetaxel Improves Survival in Metastatic Hormone-Sensitive Prostate Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 549 - 549
  • [2] Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
    Kartolo, Adi
    Tannock, Ian F.
    Badillo, Francisco E. Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3573 - +
  • [3] Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
    Lendorf, Maria Elisabeth
    Petersen, Peter Meidahl
    Svendsen, Andrea Steen
    Lindberg, Henriette
    Brasso, Klaus
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 25 - 33
  • [4] Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
    de Groot, Ietsen
    Brinkman, Ithamar
    Luijendijk-de Bruin, Daphne
    Poort, Sharon
    van Rooijen, Johan M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 33 : 48 - 55
  • [5] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [6] Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer
    Lage, Daniel E.
    Michaelson, Dror M.
    Lee, Richard J.
    Greer, Joseph A.
    Temel, Jennifer S.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [7] Early docetaxel-resistance in metastatic hormone-sensitive prostate cancer.
    Bukhari, Nedal
    Potvin, Kvica R.
    Ernst, D. Scott
    Sax, Lori
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [8] Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
    Talwar, Harkirat Singh
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (03) : 288 - 290
  • [9] Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer?
    Liaw, Bobby C.
    Oh, William K.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (09) : 17 - 20
  • [10] Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer
    Daniel E. Lage
    M. Dror Michaelson
    Richard J. Lee
    Joseph A. Greer
    Jennifer S. Temel
    Christopher J. Sweeney
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 1181 - 1188
12345